Position in MGNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$8,670
+$3,840 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. MGNX ranks #297 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in MGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,670 | 3,000 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,830 | 3,000 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,040 | 3,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $626 | 518 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,748 | 30,511 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $96,973 | 29,838 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $67,530 | 20,526 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $89,148 | 20,976 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $304,821 | 20,708 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $173,602 | 18,046 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $67,462 | 14,477 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $128,324 | 23,986 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $77,830 | 10,855 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,234 | 184 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,511 | 3,616 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,495 | 4,236 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $330,947 | 37,565 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $917,401 | 57,159 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,835,912 | 87,675 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,800,368 | 104,258 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,514,259 | 141,735 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,034,503 | 132,743 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,405,550 | 55,798 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,447,622 | 51,849 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $259,565 | 44,599 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||